Esco Cap Lunch Presentation in Zurich

Esco Cap Lunch Presentation in Zurich organized by EsoCap AG

Club zum Rennweg, Fortunagasse, Zürich, Switzerland

View map

EsoCap AG (‘EsoCap’) is offering an equity investment of CHF 10 million in a private placement at CHF 28 per share, representing a pre-money valuation of CHF 77.5 million.

The funds from this offering will be used to roll out the international patent portfolio, prepare the pivotal Phase III clinical trial, interact with regulatory authorities in the US and Europe, scale up industrially, and produce clinical trial material.  

EsoCap is in the process of preparing a commercial transaction with a major pharmaceutical company specialising in gastroenterology and cancer. The goal is a trade sale projected at around 300m CHF.

About EsoCap

EsoCap AG is a privately funded joint stock company based in Basel, Switzerland.

EsoCap has successfully developed a unique, highly sophisticated platform technology with multiple applications for local drug therapy in patients with severe oesophageal diseases.

EsoCaps technology guarantees a significantly longer contact time of drugs (small molecules, peptides, biologics, and encapsulated mRNA treatment principles) in the oesophagus, resulting in a safe and highly effective treatment outcome.

The lead candidate ESO-101 has received Orphan Drug Designation from the US Food & Drug Administration (FDA) for the treatment of eosinophilic oesophagitis (EoE). EsoCap recently successfully completed the double-blind, randomised, placebo-controlled Phase II ACESO study with ESO-101 in five countries, demonstrating the clinical applicability of the platform technology.

EsoCap has a strong and diversified intellectual property position as well as a highly complementary team and development infrastructure.

For more information, please visit www.esocapbiotech.com and follow EsoCap on LinkedIn and Twitter.

Contact:

Isabelle Racamier

CEO

isabelle.racamier@esocapbiotech.com

Phone: +43 699 149 50 300


For the lunch presentation on 24th October: Sign up here or send an email to Martin.Signer@SmartMoneyMatch.com

Speakers

Sponsors

Presenting company

EsoCap AG

Privately held; Founded in 2017
1 - 5 employees
1 followers

100% positive feedbacks


Register

Ticket information

Organizer contact

Privately held , founded in 2017

1 - 5 employees

Investment service provider

100% positive feedbacks